“Changing the Game in Cancer” through workplace wellbeing, diversity of clinical trial operations and improved data sharing will be among the topics for discussion at our Annual Meeting and Conference to be held online Sept. 22.
We’ll also talk with Bob Ingram, our Founding Chairman, about the work he’s now doing as a member of the President’s Cancer Panel.
The CEO Roundtable on Cancer Annual Meeting and Conference led by Chairman Bob Bradway, Chairman and Chief Executive Officer of Amgen, is going online because of the phased reopening of states post coronavirus. But this opens the door for wider participation by member staff without the time and expense of travel.
Breakout sessions are being designed for leaders in R&D, public policy, human relations, benefits, community affairs, inclusion and diversity, corporate responsibility, and marketing.
The event begins with the Annual Meeting for official company representatives from 11 a.m. until noon.
Everyone is invited for the 12:15-1:15 p.m. session about the President’s Cancer Panel. Then breakout sessions will follow from 1:30-2 p.m. and be repeated from 2:15-3 p.m.
More details will follow by email but please mark your calendar.